Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EUDA Health Holdings (EUDA) Common Equity (2021 - 2025)

EUDA Health Holdings (EUDA) has disclosed Common Equity for 4 consecutive years, with -$2.6 million as the latest value for Q4 2024.

  • Quarterly Common Equity rose 65.88% to -$2.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$2.6 million through Dec 2024, up 65.88% year-over-year, with the annual reading at -$2.6 million for FY2024, 65.88% up from the prior year.
  • Common Equity for Q4 2024 was -$2.6 million at EUDA Health Holdings, up from -$7.5 million in the prior quarter.
  • The five-year high for Common Equity was $821030.0 in Q1 2022, with the low at -$7.5 million in Q4 2023.
  • Average Common Equity over 4 years is -$3.0 million, with a median of -$3.0 million recorded in 2022.
  • The sharpest move saw Common Equity crashed 825.13% in 2023, then skyrocketed 65.88% in 2024.
  • Over 4 years, Common Equity stood at $600050.0 in 2021, then tumbled by 684.46% to -$3.5 million in 2022, then crashed by 113.34% to -$7.5 million in 2023, then skyrocketed by 65.88% to -$2.6 million in 2024.
  • According to Business Quant data, Common Equity over the past three periods came in at -$2.6 million, -$7.5 million, and -$6.0 million for Q4 2024, Q4 2023, and Q1 2023 respectively.